abstract |
The application relates to the general formula E-3,4-dihydroxystyryl sulfonamide and the use of sulfonate compound I in the preparation of neuroprotective drugs or pharmaceutical compositions for neurodegenerative diseases, the definition of each group in the formula As stated in the claims. The invention also relates to processes for the preparation of said compounds. General formula I (wherein X is N or O) |